Complex restrictive pulmonary function pattern in connective tissue disorders (CTD) with interstitial lung disease (ILD)

J. Brea Folco (CABA, Argentina), C. Legarreta (CABA, Argentina), G. Onofre (CABA, Argentina)

Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Disease area: Airway diseases, Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Brea Folco (CABA, Argentina), C. Legarreta (CABA, Argentina), G. Onofre (CABA, Argentina). Complex restrictive pulmonary function pattern in connective tissue disorders (CTD) with interstitial lung disease (ILD). 773

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

UIP-like or NSIP pattern in interstitial lung disease patients (ILD), following by ‘connective tissue disease ‘(CTD)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012

What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Etablishing rhesus model of pulmonary fibrosis (PF) for the new drug evaluation
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

The impact of definition of ILD on WHO group Classification of PH in scleroderma
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD)
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD)
Source: International Congress 2014 – ILDs 4
Year: 2014


Forced oscillation technique in patient with scleroderma, idiopathic pulmonary fibrosis (IPF) and connective tissue diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 31s
Year: 2002

Respiratory function in systemic sclerosis patients
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015


Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013

Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Lung structure and function relation in systemic sclerosis: Application of lung densitometry
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015

Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Pulmonary function involvement in scleroderma
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016